Impaired fasting glucose as a predictor of future diabetes

被引:0
|
作者
Tsur, A
Cohen, Y
Yerushalmi, Y
Ravid, M
Raz, I
Wainstein, J
机构
[1] Clalit Hlth Serv, Diabet & Endocrinol Clin, Jerusalem, Israel
[2] Maccabi Hlth Serv, Diabet Clin, Jaffa, Israel
[3] Zamenhof Clin, Diabet & Endocrinol Clin, Tel Aviv, Israel
[4] Meir Hosp, Diabet Unit, Kefar Sava, Israel
[5] Hadassah Hebrew Univ Hosp, Diabet Unit, Jerusalem, Israel
[6] Wolfson Med Ctr, Diabet Clin, Holon, Israel
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
384
引用
收藏
页码:A144 / A144
页数:1
相关论文
共 50 条
  • [41] Gestational diabetes, prevalence of metabolic syndrome, impaired fasting glucose and progression to diabetes
    Kimball-Ravari, L
    Djedjos, S
    Bejjanki, S
    Behm, T
    Ali, W
    Ton, A
    Yaturu, S
    DIABETES, 2005, 54 : A676 - A676
  • [42] Impaired fasting glucose: a predictor of increased morbidity and mortality in patients with heart failure
    Gotsman, I.
    Zwas, D.
    Admon, D.
    Lotan, C.
    Keren, A.
    EUROPEAN HEART JOURNAL, 2011, 32 : 664 - 664
  • [43] Anthropometric Indicators as Predictor of Impaired Fasting Glucose Status of Adults in South Tangerang
    Nisa, Hoirun
    Fatihah, Imanda Zein
    BULETIN PENELITIAN SISTEM KESEHATAN, 2020, 23 (04): : 267 - 274
  • [44] Impaired fasting glucose: a predictor of increased morbidity and mortality in patients with heart failure
    Gotsman, I.
    Zwas, D.
    Admon, D.
    Lotan, C.
    Keren, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 664 - 664
  • [45] Prediction of post challenge diabetes and impaired glucose tolerance among those without diabetes by fasting glucose
    Schmidt, MI
    Duncan, BB
    Pankow, JS
    Ballantyne, CM
    Brancati, FL
    Chambless, LE
    DIABETES, 2002, 51 : A237 - A237
  • [46] Fasting Blood Glucose as a Predictor of Medical Management in Gestational Diabetes Mellitus
    Zhu, S.
    Sivanesan, K.
    Meehan, T.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2021, 61 : 138 - 138
  • [47] Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial
    Gerstein, H. C.
    Yusuf, S.
    Holman, R. R.
    Bosch, J.
    Anand, S.
    Avezum, A.
    Budaj, A.
    Chiasson, J.
    Conget, I.
    Dagenais, G.
    Davis, M.
    Diaz, R.
    Dinccag, N.
    Enjalbert, M.
    Escalante, A.
    Fodor, G.
    Hanefeld, M.
    Hedner, T.
    Jolly, K.
    Keltai, M.
    Laakso, M.
    Lanas, F.
    Lonn, E.
    McQueen, M.
    Mohan, V.
    Phillips, A.
    Piegas, L.
    Pirags, V.
    Probstfield, J.
    Shaw, J.
    Schmid, I.
    Teo, K.
    Zimmet, P.
    Zinman, B.
    Gerstein, H. C.
    Yusuf, S.
    Bosch, J.
    Pogue, J.
    Sheridan, P.
    Dinccag, N.
    Hanefeld, M.
    Hoogwerf, B.
    Laakso, M.
    Mohan, V.
    Shaw, J.
    Zinman, B.
    Holman, R. R.
    Diaz, R.
    Ahuad Guerrero, R.
    Albisu, J.
    LANCET, 2006, 368 (9541): : 1096 - 1105
  • [48] Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study
    R. M. van Dam
    J. M. Dekker
    G. Nijpels
    C. D. A. Stehouwer
    L. M. Bouter
    R. J. Heine
    Diabetologia, 2004, 47 : 2152 - 2159
  • [50] High leptin levels predict development of diabetes and impaired glucose tolerance but not impaired fasting glucose in the Mauritius cohort
    Soderberg, S
    Shaw, J
    Tuomilehto, J
    Alberti, KGMM
    Zimmet, P
    DIABETES, 2002, 51 : A29 - A30